Liver Disease – Ayurved Healing

Katuki and Bhumyamalaki: The Ayurvedic Hepatitis B Support Duo

Dr. Ananya Sharma — Wed, 22 Jul 2026 07:30:00 +0000

Hepatitis B Through the Ayurvedic Lens: Yakrit Roga and the Pitta-Rakta Connection

Hepatitis B remains one of the most persistent viral infections worldwide, affecting hundreds of millions of people chronically according to global health estimates. While modern antiviral therapy such as tenofovir and entecavir has significantly improved outcomes, many patients seek adjunctive support for liver protection, immune balance, and relief from fatigue and digestive weakness that may persist despite viral suppression.

In classical Ayurvedic literature, hepatitis-like presentations are described under yakrit roga (liver disorders) and kamala (jaundice conditions). Kamala is understood as a disorder arising from aggravated pitta, particularly ranjaka pitta located in the liver and blood tissues (rakta dhatu), leading to impaired bile metabolism and systemic discoloration. Clinical features such as yellowing of the eyes and skin, dark urine, pale stools, fatigue, and loss of appetite closely resemble hepatitis presentations.

Within the Ayurvedic framework, the liver (yakrit) is considered a central organ for blood purification and pitta regulation. Management focuses on three coordinated objectives: pacifying aggravated pitta, protecting hepatic tissue, and supporting functional regeneration of liver metabolism. Two herbs most commonly emphasized in this context are katuki (Picrorhiza kurroa) and bhumyamalaki (Phyllanthus niruri).

Katuki (Picrorhiza kurroa): The Bitter Hepatoprotective Herb

Katuki, also known as kutki, is a perennial Himalayan herb traditionally valued for its intensely bitter taste (tikta rasa), which is considered highly effective in pacifying aggravated pitta and supporting liver function. It is primarily used in conditions involving impaired digestion, toxin accumulation, and hepatic sluggishness.

Classical Positioning

Traditional Ayurvedic nighantus describe katuki as beneficial for liver and spleen disorders, fever conditions, and pitta imbalance. It is regarded as a strong bitter herb that supports bile regulation, digestion, and metabolic cleansing processes associated with yakrit function.

Its bitter compounds, mainly iridoid glycosides such as picrosides, are considered responsible for its hepatoprotective and antioxidant activity, supporting its traditional use in liver-related disorders.

Modern Pharmacological Understanding

Experimental and clinical literature has reported hepatoprotective, antioxidant, and anti-inflammatory activity of Picrorhiza kurroa. These effects are attributed to modulation of oxidative stress pathways and support of endogenous antioxidant systems involved in hepatic protection.

Clinical observations in viral hepatitis contexts have noted improvements in liver enzyme patterns and bilirubin metabolism when katuki-based preparations are used as supportive therapy alongside standard medical care.

Dosage and Preparation

Katuki is traditionally administered in several forms depending on patient tolerance and clinical condition:

Churna (powder): 1–3 grams twice daily with warm water or honey.
Extract tablets (Ghana Vati): 250–500 mg twice daily for those sensitive to bitter taste.
Arogyavardhini Vati: 250–500 mg twice daily, used under careful supervision due to its mineral content and multi-herb composition.

Bhumyamalaki (Phyllanthus niruri): The Viral-Targeted Liver Herb

Bhumyamalaki is a small tropical herb widely used in Ayurveda for liver disorders, jaundice conditions, and urinary regulation. It is traditionally classified as pitta-pacifying and supportive in yakrit and spleen-related disorders.

Traditional Context

Bhumyamalaki is described in Ayurvedic texts as beneficial in conditions involving excess pitta, impaired bile flow, and hepatic dysfunction. It is valued for its cooling, detoxifying, and supportive effects on liver metabolism.

Research and Experimental Insights

Experimental studies on Phyllanthus species have reported antiviral activity against hepatitis B virus replication pathways, including inhibition of viral polymerase activity and modulation of viral antigen expression in infected liver cells.

Variability in clinical outcomes has been observed across studies due to differences in plant species, extract preparation, and treatment duration, but hepatoprotective and liver-supportive effects are consistently reported in experimental literature.

Dosage and Preparation

Fresh juice (swarasa): 10–20 ml twice daily.
Powder: 3–5 grams twice daily with water.
Standardized extract: 500 mg twice daily.
Decoction (kwatha): 50–100 ml twice daily.

The Synergy of Katuki and Bhumyamalaki

In Ayurvedic therapeutics, synergistic combinations (yoga) are designed to address multiple dimensions of disease simultaneously. Katuki and bhumyamalaki complement each other in hepatic disorders by supporting different functional pathways.

Therapeutic Target	Katuki Contribution	Bhumyamalaki Contribution
Hepatocyte Protection	Strong support through bitter phytochemicals	Moderate antioxidant support
Anti-inflammatory Action	Strong pitta-pacifying activity	Moderate anti-inflammatory activity
Antiviral Activity	Minimal direct action	Supportive antiviral activity against HBV pathways
Bile Flow Regulation	Strong cholagogue effect	Mild supportive action
Liver Detoxification	Strong metabolic stimulation	Moderate detoxifying support
Immune Modulation	Mild regulatory effect	Moderate immune modulation

Together, these herbs are traditionally used to support liver function, regulate pitta imbalance, and assist in maintaining metabolic stability in chronic hepatic conditions when used alongside appropriate medical supervision.

Clinical Protocol: Supportive Ayurvedic Framework for Chronic Hepatitis B

This protocol represents a traditional Ayurvedic supportive approach used alongside standard antiviral therapy. Individualization based on liver function, viral load, and overall health status is essential.

Phase 1: Assessment and Baseline (Week 1)

Baseline evaluation includes liver function tests (ALT, AST, bilirubin profile, albumin), HBV DNA levels, HBeAg status, complete blood count, and imaging such as ultrasound or FibroScan when available.

Ayurvedic assessment focuses on prakriti (constitution), agni (digestive strength), and signs of pitta-rakta imbalance such as fatigue, digestive irregularity, and skin discoloration.

Phase 2: Active Supportive Care (Months 1–6)

Katuki churna: 2 grams twice daily before meals with warm water
Bhumyamalaki churna: 3 grams twice daily after meals
Aloe vera juice: 15–20 ml once daily on an empty stomach
Guduchi (Tinospora cordifolia): 500 mg twice daily as an immunomodulatory herb

This herbal protocol is used as an adjunct to antiviral therapy and is not intended to replace prescribed medical treatment. Coordination with the treating physician is essential.

Phase 3: Monitoring

Liver function tests and viral markers are monitored periodically to assess disease progression and hepatic response. Clinical signs such as appetite, energy levels, and digestion are also evaluated as part of overall assessment.

Phase 4: Maintenance

After initial improvement, lower maintenance doses may be used under supervision to support ongoing liver health and metabolic balance.

Dietary Framework for Liver Support

Diet plays a central role in Ayurvedic management of hepatic disorders. A pitta-pacifying dietary approach is recommended.

Recommended: Bitter vegetables, leafy greens, mung dal, barley, pomegranate, grapes, and lightly prepared warm foods.
Avoid: Alcohol, excessively spicy foods, deep-fried foods, processed foods, and excessive sour or fermented items.
Carrier substances: Warm water or buttermilk may be used to support herbal absorption and digestion.

Safety Considerations

Herbal interventions must be used cautiously in chronic liver disease. Dose adjustments are required in advanced liver impairment. Immunomodulatory herbs should be used carefully in patients on immunosuppressive therapy. Katuki and bhumyamalaki are not recommended during pregnancy. Professional supervision is essential in all cases involving chronic hepatitis B.

Clinical Perspective

Chronic hepatitis B requires lifelong monitoring and coordinated care. Ayurvedic herbal support may assist in maintaining liver function, digestive strength, and overall well-being when used alongside antiviral therapy and regular medical supervision. Consistency, individualized dosing, and integration with modern hepatology provide the most balanced approach.

Medical Disclaimer: This content is for educational purposes only. Hepatitis B is a serious medical condition requiring supervision by qualified healthcare professionals. Ayurvedic interventions should be used only as supportive care alongside standard treatment and under expert guidance.

This article does not diagnose or treat disease. Always consult a qualified physician before starting or modifying any treatment.

References

Non-Alcoholic Fatty Liver (NASH) Beyond NAFLD: Advanced Ayurvedic Protocol

Dr. Meera Iyer — Fri, 03 Jul 2026 09:00:00 +0000

A practical NASH plan often begins with a difficult clinical reality: a person may lose weight, improve glucose control, and still have ongoing liver inflammation or fibrosis risk. That is why NASH, now commonly grouped under the term MASH, needs more than a generic “fatty liver” plan. The aim is to protect liver tissue, reduce metabolic stress, support digestion and elimination, and keep medical monitoring active throughout treatment.

NASH/MASH is the inflammatory form of metabolic fatty liver disease. It involves excess fat in the liver along with hepatocyte injury and inflammatory activity, and it may progress into fibrosis, cirrhosis, or hepatocellular carcinoma in vulnerable patients. In Ayurvedic language, this pattern is best approached through the combined lenses of impaired Agni, Ama accumulation, Meda-Kapha excess, Pitta involvement, Rakta-Yakrit stress, and Srotas obstruction. The herbs below are not a substitute for hepatology care; they are best used as a structured adjunct under qualified supervision.

Yakrit Roga: The Classical Framework for Liver Support

Classical Ayurvedic texts describe liver-related disease through terms such as Yakrit, Kamala, Pandu, Udara, Plihodara, and Yakritodara. Charaka Samhita, Chikitsasthana, Chapter 13 discusses Udara Roga and includes Yakritodara within the broader abdominal-disease framework, while emphasizing Agni impairment, Dosha involvement, abdominal enlargement, and chronicity. This does not make NASH a direct one-to-one classical diagnosis; it gives a practical diagnostic language for assessing digestion, tissue metabolism, abdominal heaviness, Pitta signs, bowel pattern, and systemic strength.

The Ayurvedic sequence for NASH support is therefore not a single “liver detox.” It begins with Nidana Parivarjana, meaning removal of causative factors such as excess refined carbohydrate, frequent snacking, alcohol, deep-fried foods, sedentary routine, and sleep disruption. It then uses Deepana-Pachana to restore digestive efficiency, Meda-Kapha management through lightening and scraping measures, Pitta-Rakta support for inflammatory heat, and gentle Rasayana support after digestion and bowel function have stabilized.

The Five Key Herbs for NASH Support

The following herbs are useful to discuss with an Ayurvedic physician when NASH/MASH is present with metabolic syndrome, elevated liver enzymes, fatty infiltration, or fibrosis risk. The safest plan is individualized by constitution, bowel pattern, liver-test trend, medications, fibrosis stage, and the presence or absence of autoimmune liver disease.

1. Katuki (Picrorhiza kurroa) — The Bitter Yakrit Herb

Katuki, classically named Katuka, is one of Ayurveda’s important bitter herbs for Yakrit-related and Pitta-Kapha patterns. The Ayurvedic Pharmacopoeia of India describes Katuki as Katu-Tikta in taste, Laghu in quality, Ushna in potency, Katu in post-digestive effect, and having actions such as Dipani, Bhedini, Pittahara, and Jvarahara. Its classical uses include Kamala, Daha, Jvara, Arocaka, and Kushta, making it especially relevant when liver stress is accompanied by poor appetite, heaviness, sluggish bowel movement, heat, and metabolic stagnation.

For NASH support, Katuki is best viewed as a targeted physician-guided herb rather than a daily wellness supplement. It suits patients with Pitta-Kapha obstruction, poor bile flow symptoms, constipation tendency, coated tongue, and a feeling of abdominal heaviness. Because it is bitter, potent, and mildly purgative in many individuals, it should not be casually combined with multiple other strong liver herbs.

Classical dose range: the Ayurvedic Pharmacopoeia lists Katuki powder at 1-3 g. Extract dose should be decided by a practitioner according to product strength and patient tolerance. Use authenticated, cultivated or responsibly sourced material, because Picrorhiza kurroa is a conservation-sensitive Himalayan plant. Avoid self-use during pregnancy, severe diarrhea, frailty, advanced cirrhosis, or decompensated liver disease.

2. Bhumi Amla / Tamalaki (Phyllanthus fraternus; Phyllanthus niruri group) — The Pitta-Meda Liver Support

Bhumi Amla, classically listed as Tamalaki in the Ayurvedic Pharmacopoeia of India, is identified there as Phyllanthus fraternus Webster, with Phyllanthus niruri Hook.f. non Linn. noted in synonymy. It is described as Madhura-Tikta-Kashaya in taste, Laghu and Ruksha in quality, Shita in potency, Madhura in post-digestive effect, and having actions such as Mutrala, Rocana, Dahanashani, and Pittashamaka. Classical indications include Amlapitta, Pandu, Prameha, Trsha, Mutraroga, and related Pitta-Meda presentations.

In a NASH-oriented plan, Bhumi Amla is most useful where fatty liver is accompanied by Pitta signs such as acidity, heat, thirst, irritability, bitter taste, or burning sensation, along with metabolic markers such as prediabetes or dyslipidemia. Botanical identity matters because commercial “Phyllanthus” products may vary by species, plant part, extraction method, and strength.

Classical dose range: the Ayurvedic Pharmacopoeia lists Tamalaki fresh juice at 10-20 ml and powder at 3-6 g. When combined with Katuki, dosing should be conservative and supervised, especially if liver enzymes are already abnormal or the patient is taking antidiabetic, anticoagulant, lipid-lowering, or hepatology medicines.

3. Guduchi (Tinospora cordifolia) — The Rasayana and Metabolic Support

Guduchi is described in the Ayurvedic Pharmacopoeia of India as Tikta-Kashaya in taste, Laghu in quality, Ushna in potency, Madhura in post-digestive effect, and having actions such as Balya, Dipana, Rasayana, Sangrahi, Tridoshashamaka, Raktashodhaka, and Jvaraghna. Its listed indications include Jvara, Kushta, Pandu, Prameha, Vatarakta, and Kamala, placing it in a useful position for chronic metabolic, inflammatory, and liver-associated patterns.

For NASH support, Guduchi is best suited when liver stress is accompanied by fatigue, low resilience, Prameha tendency, inflammatory reactivity, recurrent low-grade feverishness, or post-illness weakness. It is not merely a “liver cleanser”; it is a Rasayana-type support that should be chosen according to constitution, digestion, bowel pattern, and immune history.

Classical dose range: the Ayurvedic Pharmacopoeia lists Guduchi stem powder at 3-6 g and decoction prepared from 20-30 g of the drug. Because liver injury has been reported in some people using Tinospora products, especially where autoimmune hepatitis is known or suspected, Guduchi should be used only with professional guidance in NASH. Stop and seek medical review if jaundice, dark urine, severe itching, unusual fatigue, right-sided abdominal pain, or liver-enzyme worsening appears.

4. Kumari / Kanyasara (Aloe barbadensis, Aloe vera) — The Bhedana and Metabolic Adjunct

Kumari is widely known as aloe, but Ayurvedic and commercial aloe preparations are not all the same. The Ayurvedic Pharmacopoeia of India lists Kanyasara as the dried juice of leaves of Aloe barbadensis Miller, with actions such as Bhedi, Pittanirharana, Rajahpravartaka, and Jvaranut, and indications that include Udararoga and Yakrdvikara. This classical preparation is stronger and more purgative than ordinary food-grade inner aloe gel.

In a NASH plan, aloe is useful only when selected carefully. Fresh inner leaf gel or properly processed decolorized aloe products are very different from aloe latex, the yellow bitter layer near the rind. Oral aloe latex is not appropriate as a daily liver tonic and may cause cramping, diarrhea, electrolyte disturbance, kidney injury, or dangerous dehydration in susceptible people.

Classical dose range: the Ayurvedic Pharmacopoeia lists Kanyasara powder at 125-500 mg. For home use, do not scrape or consume the yellow latex layer. Patients with diarrhea, kidney disease, pregnancy, inflammatory bowel disease, advanced liver disease, or use of diuretics, digoxin, diabetes medicines, or anticoagulants should avoid unsupervised aloe use.

5. Amalaki (Emblica officinalis / Phyllanthus emblica) — The Gentle Rasayana Foundation

Amalaki is one of Ayurveda’s most important Rasayana herbs and is generally better suited for longer-term support than harsher purgative herbs. The Ayurvedic Pharmacopoeia describes Amalaki as having five tastes except Lavana, with Amla prominent; Laghu and Ruksha qualities; Shita potency; Madhura post-digestive effect; and actions such as Tridoshajit and Rasayana. Its listed uses include Amlapitta, Prameha, Daha, and Raktapitta-related presentations.

For NASH support, Amalaki is especially useful where metabolic liver disease coexists with acidity, heat, oxidative stress, dyslipidemia tendency, or fatigue after digestion has become irregular. It can be used as a foundation herb in many plans because it is gentler than Katuki or aloe latex-type preparations and pairs well with dietary correction.

Classical dose range: the Ayurvedic Pharmacopoeia lists dried Amalaki powder at 3-6 g and fresh juice at 5-10 ml. Patients on antidiabetic or anticoagulant medicines should still discuss regular use with a clinician, because metabolic markers and medication needs may change as diet and weight improve.

A Stage-Based Adjunct Plan

NASH/MASH staging should be guided by a hepatologist using liver enzymes, platelet count, FIB-4, ultrasound, transient elastography, MRI-based assessment, biopsy when indicated, and metabolic-risk review. Ayurveda can be layered as an adjunct, but the intensity of herbal therapy must decrease as cirrhosis risk increases.

Clinical Situation	Ayurvedic Emphasis	Herbs to Discuss	Monitoring
MASLD / fatty liver without fibrosis or active inflammation	Agni correction, Meda-Kapha reduction, daily movement, early metabolic correction	Amalaki, Guduchi, or Tamalaki according to constitution and symptoms	ALT, AST, GGT, HbA1c, fasting lipids, waist circumference, and weight trend
Early NASH/MASH with F1-F2 fibrosis or persistent enzyme elevation	Deepana-Pachana, Pitta-Meda management, bowel regularity, strict diet correction	Short supervised Katuki course with Tamalaki or Amalaki; avoid stacking many extracts	Liver panel at clinician-set intervals; FIB-4 and elastography as advised
Significant fibrosis, commonly F2-F3	Conservative adjunctive care, no aggressive cleansing, coordinated medical management	Individualized low-intensity plan; consider whether the patient is eligible for approved hepatology treatment	Hepatologist review, fibrosis assessment, platelet count, liver panel, diabetes and lipid control
Cirrhosis risk or F4 / decompensated liver disease	Safety-first supportive care only	No self-directed purgatives, detoxes, latex aloe, or strong multi-herb protocols	Specialist-led surveillance for complications, varices, ascites, encephalopathy, and liver cancer risk

Dietary Protocol: The Agni-Meda Connection

No herbal plan for NASH can succeed without dietary and lifestyle transformation. In Ayurvedic terms, the core work is Langhana for Meda-Kapha excess, Deepana-Pachana for weak or obstructed Agni, and removal of Ama-forming habits. This means reducing refined flour, sugar, sweet drinks, frequent snacking, deep-fried foods, excess dairy sweets, alcohol, and heavy late dinners. Meals should be warm, simple, protein-adequate, fiber-rich, and built around vegetables, legumes when tolerated, whole grains in measured portions, and bitter or astringent foods such as methi, karela, leafy greens, turmeric, and amla.

Modern liver-care targets align with this discipline: sustained weight reduction can reduce liver fat, greater weight loss may improve inflammatory activity, and larger sustained reduction is associated with better fibrosis outcomes. A Mediterranean-like dietary pattern, avoidance of sugary beverages and ultra-processed foods, and regular physical activity are central. A practical minimum exercise target is more than 150 minutes per week of moderate activity or an equivalent vigorous routine, adjusted for age, fitness, cardiac status, and joint health.

For further reading on the metabolic connection between gut, inflammation, and skin, see the article on the gut-skin axis and Rakta Pitta theory. The Daruharidra and berberine comparison to metformin is also relevant for the metabolic syndrome component of fatty liver disease.

When to Stop Herbs and Seek Medical Review

Stop herbal products and seek medical care promptly if jaundice, dark urine, pale stool, severe itching, new right-upper-abdominal pain, persistent vomiting, swelling of the legs or abdomen, confusion, black stools, vomiting blood, rapid unexplained weight loss, or sudden worsening fatigue occurs. Also stop and review the plan if ALT, AST, bilirubin, INR, or platelet count worsens after starting an herb.

Safety disclaimer: NASH/MASH is a serious progressive liver condition that requires medical diagnosis and monitoring. Ayurvedic herbs should be used as adjuncts, not replacements for hepatology care, diet therapy, weight management, diabetes control, lipid management, and approved medical treatment when indicated. Consult a qualified Ayurvedic practitioner and a healthcare provider before using Katuki, Guduchi, Bhumi Amla, Kumari, Amalaki, or any liver formula, especially during pregnancy, breastfeeding, autoimmune hepatitis, cirrhosis, kidney disease, gallbladder disease, diabetes-medication use, anticoagulant use, immunosuppressant use, or when taking statins, GLP-1 medicines, SGLT2 inhibitors, or resmetirom.